Metraipolis › archive › dc_f44a50a656db

Topical application of the antimuscarinic pirenzepine increased lower limb nerve fibre density in a phase 2a study in type 2 patients with diabetes with… — Europe PMC PMID:41352124

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41352124
DOI
10.1016/j.ebiom.2025.106055
License (as archived)
solo-consultazione
Archived
2026-11-07T21:35:24.488Z
SHA-256 of the archived text
b18171e09e60d65a6b963dcceb051ddd81b1b6fafd10c5a16790d660ee57d1b9
Stable URL of this page
https://metraipolis.com/documento/dc_f44a50a656db

How to cite

Topical application of the antimuscarinic pirenzepine increased lower limb nerve fibre density in a phase 2a study in type 2 patients with diabetes with… — Europe PMC PMID:41352124 — Europe PMC (en), https://europepmc.org/article/MED/41352124 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f44a50a656db (Metraipolis archive dc_f44a50a656db, sha256 b18171e09e60d65a6b963dcceb051ddd81b1b6fafd10c5a16790d660ee57d1b9)
BibTeX
@misc{dcf44a50a656db,
  title = {Topical application of the antimuscarinic pirenzepine increased lower limb nerve fibre density in a phase 2a study in type 2 patients with diabetes with… — Europe PMC PMID:41352124},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41352124},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f44a50a656db; sha256 b18171e09e60d65a6b963dcceb051ddd81b1b6fafd10c5a16790d660ee57d1b9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41352124. Agents can read the archived copy with the MCP tool read_document.